Advertisement

Topics

Equaline 44-112 | Nasal Decongestant

12:43 EDT 24th July 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.
adults and children
12 years and older 
take 2 tablets every 4 to 6 hours;
do not take more than 8 tablets in
24 hours 
children ages 6 to 12 years take 1 tablet every 4 to 6 hours;
do not take more than 4 tablets in
24 hours 
children under 6 years do not use this product in children
under 6 years of age 

@font-face { font-family: Cambria; } @page Section1 {size: 8.5in 11.0in; margin: 1.0in 1.25in 1.0in 1.25in; mso-header-margin: .5in; mso-footer-margin: .5in; mso-paper-source: 0; } P.MsoNormal { MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; FONT-SIZE: 12pt; mso-style-parent: ""; mso-pagination: widow-orphan; mso-ascii-font-family: Helvetica; mso-fareast-font-family: Cambria; mso-hansi-font-family: Helvetica; mso-bidi-font-family: "Times New Roman" } LI.MsoNormal { MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; FONT-SIZE: 12pt; mso-style-parent: ""; mso-pagination: widow-orphan; mso-ascii-font-family: Helvetica; mso-fareast-font-family: Cambria; mso-hansi-font-family: Helvetica; mso-bidi-font-family: "Times New Roman" } DIV.MsoNormal { MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; FONT-SIZE: 12pt; mso-style-parent: ""; mso-pagination: widow-orphan; mso-ascii-font-family: Helvetica; mso-fareast-font-family: Cambria; mso-hansi-font-family: Helvetica; mso-bidi-font-family: "Times New Roman" } DIV.Section1 { page: Section1 }The product packaging shown below represents a sample of that currently in use.  Additional packaging may also be available.

equaline®

compare to Sudafed® Nasal

Decongestant active ingredient*

NDC 41163-112-08

non-drowsy • maximum strength

nasal

decongestant

pseudoephedrine HCl

relieves:

• nasal & sinus congestion

• sinus pressure

12 doses

2 pills/dose

24 tablets, 30 mg each

TAMPER EVIDENT: DO NOT USE IF CARTON IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

50844     ORG031011208

DISTRIBUTED BY SUPERVALU INC.

EDEN PRAIRIE, MN 55344 USA

Manufacturer

SUPERVALU INC.

Active Ingredients

Source

Clinical Trials [947 Associated Clinical Trials listed on BioPortfolio]

Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-Allergic Rhinitis in Subjects With Persistent Nasal Congestion

Nasal glucocorticosteroids (GCS) are considered first-line therapy for both allergic and non-allergic rhinitis.1-3 Nasal congestion can persist despite maximum treatment with intranasal G...

Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation

The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methampheta...

Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?

We hypothesize that those patients with purely seasonal allergic rhinitis will decongest better than those subjects with another cause contributing to their symptoms. These latter patient...

A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge

An H3 receptor antagonist should reduce the congestion associated with allergic rhinitis. A nasal allergen challenge will be given to patients to induce rhinitis symptoms and acoustic rhi...

Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

The aim of this study is to characterize the time profile of the decongestant properties of xylometazoline and to investigate its effect on sleep, general well-being and smell/taste.

PubMed Articles [589 Associated PubMed Articles listed on BioPortfolio]

Effects of Common Cold and Concomitant Administration of Nasal Decongestant on the Pharmacokinetics and Pharmacodynamics of Nasal Glucagon in Otherwise Healthy Participants: a randomized clinical trial.

Nasal glucagon (NG) is a nasally-administered glucagon powder, absorbed through the nasal mucosa, designed for treatment of severe hypoglycaemia. This study evaluated safety, pharmacokinetics (PK), an...

Safety of the use of xylometazoline nasal spray in young children undergoing lacrimal surgery: an observational study.

It is common practice to prepare the nasal mucosa with decongestant in children undergoing lacrimal surgery. Xylometazoline 0.05% (Otrivine) nasal spray is commonly used. It has been reported to cause...

Prolonged denervation induces remodeling of nasal mucosa in rat model of posterior nasal neurectomy.

The posterior nasal nerve is the dominant source of the parasympathetic, sympathetic, and sensory fibers that innervate the nasal respiratory mucosa. Therefore, a posterior nasal neurectomy (PNN) indu...

Finesse in Nasal Tip Refinement.

Nasal tip refinement is one of the most difficult aspects of rhinoplasty surgery. In this article, the senior author (R.J.R.) presents his technique for nasal tip analysis and identifies the factors t...

Comparison between unilateral PNIF and rhinomanometry in the evaluation of nasal cycle.

Human unilateral nasal airflow shows spontaneous changes over a period of hours due to the alternating congestion and decongestion of the venous sinuses within the nasal turbinates and nasal septum. T...

Quick Search
Advertisement
 

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record